What is the best topical anti-androgen for stopping hair loss?

Videos mentioned:
Pyrilutamide:
   • Pyrilutamide results are in!  The fut...  
   • Pyrilutamide phase II trial data leak...  
   • Pyrilutamide, the best thing for hair...  
RU58841 and Fluridil:
   • RU58841 vs Fluridil for hair loss  
   • RU58841 vs Fluridil for hair loss  
   • RU58841 vs Finasteride for hair loss  
   • Does RU58841 for hair loss cause hear...  
   • Finasteride vs fluridil for hair loss  
Breezula:
   • Finasteride vs Breezula.  Which is be...  
DHT trash hormone:
   • DHT is a trash hormone part 5: Finast...  
   • Testosterone vs DHT.  Which is more i...  
   • DHT is a trash hormone part 4.  DHT c...  
   • DHT is a trash hormone part 3: Return...  
   • DHT is a trash hormone Part Deux Elec...  
GT20029:
   • GT20029 data released.  We are one st...  
   • The Cure For Hair Loss!  GT20029  

Sources:
1. Government of Canada I. Canadian Patent Database / Base de données sur les brevets canadiens. Accessed December 17, 2022. https://www.ic.gc.ca/opic-cipo/cpd/en...
2. Kuzmi P. Why IC50’s Are Bad for You.
3. Cortexolone 17α-propionate (Clascoterone) Is a Novel Androgen Receptor Antagonist that Inhibits Production of Lipids and Inflammatory Cytokines from Sebocytes In Vitro - JDDonline - Journal of Drugs in Dermatology. Accessed December 18, 2022. https://jddonline.com/articles/cortex...
4. Cyproterone Acetate | ≥99%(HPLC) | Selleck | Androgen Receptor antagonist. selleckchem.com. Accessed December 19, 2022. https://www.selleckchem.com/products/...
5. Does IC-50 values of ligand or inhibitor depend on the concentration of protein receptors or proteins? ResearchGate. Accessed December 17, 2022. https://www.researchgate.net/post/Doe...
6. Simard J, Luthy I, Guay J, Bélanger A, Labrie F. Characteristics of interaction of the antiandrogen flutamide with the androgen receptor in various target tissues. Mol Cell Endocrinol. 1986;44(3):261-270. doi:10.1016/0303-7207(86)90132-2
7. Battmann T, Bonfils A, Branche C, et al. RU 58841, a new specific topical antiandrogen: a candidate of choice for the treatment of acne, androgenetic alopecia and hirsutism. J Steroid Biochem Mol Biol. 1994;48(1):55-60. doi:10.1016/0960-0760(94)90250-x
8. Van Dort ME, Jung YW. Synthesis and structure-activity studies of side-chain derivatized arylhydantoins for investigation as androgen receptor radioligands. Bioorg Med Chem Lett. 2001;11(8):1045-1047. doi:10.1016/s0960-894x(01)00146-9
9. Seligson AL, Campion BK, Brown JW, et al. Development of fluridil, a topical suppressor of the androgen receptor in androgenetic alopecia. Drug Dev Res. 2003;59(3):292-306. doi:10.1002/ddr.10166
10. Celasco G, Moro L, Bozzella R, et al. Biological Profile of Cortexolone 17a-Propionate (CB-03-01), a New Topical and Peripherally Selective Androgen Antagonist. Arzneimittelforschung. 2004;54(12):881-886. doi:10.1055/s-0031-1297043
11. Cabeza M, Heuze I, Sánchez M, et al. Relative binding affinity of novel steroids to androgen receptors in hamster prostate. J Enzyme Inhib Med Chem. 2005;20(4):357-364. doi:10.1080/14756360500148924
12. Gao W, Kim J, Dalton JT. Pharmacokinetics and Pharmacodynamics of Nonsteroidal Androgen Receptor Ligands. Pharm Res. 2006;23(8):1641-1658. doi:10.1007/s11095-006-9024-3
13. Fagart J, Hillisch A, Huyet J, et al. A New Mode of Mineralocorticoid Receptor Antagonism by a Potent and Selective Nonsteroidal Molecule. Journal of Biological Chemistry. 2010;285(39):29932-29940. doi:10.1074/jbc.M110.131342
14. Ferraboschi P, Legnani L, Celasco G, Moro L, Ragonesi L, Colombo D. A full conformational characterization of antiandrogen cortexolone-17α-propionate and related compounds through theoretical calculations and nuclear magnetic resonance spectroscopy. Med Chem Commun. 2014;5(7):904-914. doi:10.1039/C4MD00049H
15. Rosette C, Agan FJ, Mazzetti A, Moro L, Gerloni M. Cortexolone 17α-propionate (Clascoterone) Is a Novel Androgen Receptor Antagonist that Inhibits Production of Lipids and Inflammatory Cytokines from Sebocytes In Vitro. J Drugs Dermatol. 2019;18(5):412-418.
16. Kalabalik-Hoganson J, Frey KM, Ozdener-Poyraz AE, Slugocki M. Clascoterone: A Novel Topical Androgen Receptor Inhibitor for the Treatment of Acne. Ann Pharmacother. 2021;55(10):1290-1296. doi:10.1177/1060028021992053
17. Siciliano T, Simons IH, Beier AMK, et al. A Systematic Comparison of Antiandrogens Identifies Androgen Receptor Protein Stability as an Indicator for Treatment Response. Life (Basel). 2021;11(9):874. doi:10.3390/life11090874